The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Prognostic associations of 25OH vitamin D in NCIC CTG MA.21, a phase III adjuvant RCT of three chemotherapy regimens (EC/T, CEF, AC/T) in high-risk breast cancer (BC).
Ana Elisa Lohmann
No relevant relationships to disclose
Judy-Anne W. Chapman
No relevant relationships to disclose
Margot J. Burnell
No relevant relationships to disclose
Mark Norman Levine
No relevant relationships to disclose
Elena Tsvetkova
No relevant relationships to disclose
Kathleen I. Pritchard
No relevant relationships to disclose
Karen A. Gelmon
No relevant relationships to disclose
Patti O'Brien
No relevant relationships to disclose
Lei Han
No relevant relationships to disclose
Hope S. Rugo
No relevant relationships to disclose
Kathy S. Albain
No relevant relationships to disclose
Edith A. Perez
No relevant relationships to disclose
Theodore A. Vandenberg
No relevant relationships to disclose
Haji I. Chalchal
No relevant relationships to disclose
Ravinder Pal Singh Sawhney
No relevant relationships to disclose
Lois E. Shepherd
No relevant relationships to disclose
Pamela Jean Goodwin
No relevant relationships to disclose